Video: Buying medicines online: The wrong click could be fatal
The European Commission posted a video lately on the danger of buying medicines online. Indeed, studies suggest that over 50% of medicines purchased from unregulated websites are falsified, counterfeit...
View ArticleArticle: Zero tolerance for counterfeit medicines: EFPIA on patient safety
“EFPIA is convinced that the way forward to ensure patient safety in the EU and beyond must be twofold: By focusing on making sure that the legitimate supply chain is as safe as possible and try to...
View ArticleAnti-counterfeiting: Finding solutions to a global problem
Counterfeiting is an age old issue. It is now a global problem where every sector of our economy has been affected. However, the consequences are different when it comes to counterfeit medicines; the...
View ArticleNew Report Highlights the Need to Ramp up the Fight against Counterfeit...
Fake medicines are now counted among the top money-making markets for crime groups in East Asia and the Pacific. This is the troubling news from a United Nations Office on Drugs and Crime (UNODC)...
View ArticleValue through the medicines lifecycle….
The UK’s National Institute for Health and Clinical Excellence (NICE) has had its fair share of headlines over the decade since it was created to advise the National Health Service on value for money....
View ArticleBrussels spin on inequalities
The imaginary Chief Psychologist of the EU has probably prescribed that from now on only good news should come from Brussels. “We need optimism”. The imaginary Chief Psychologist of the EU has probably...
View ArticleThe R&D Evolution: New Partnerships Inspire Global Approaches to Global Problems
This week the National Institutes of Health announced the launch of the Accelerating Medicines Partnership (AMP). The public private partnership falls in line with the trend towards collaborative...
View ArticleWhere Innovative Medicines Come From
“Who are the originators of innovative medicines in the EU?” – this was the title of a press release from theEMA last week, examining the origins of new medicines in the EU. It was inspired by a recent...
View ArticleEMA’s Adaptive Licensing Pilot Project Signals an Exciting Step for Medicines...
The EMA’s announcement last week of an adaptive pathway pilot project with real medicines in development is a bold step in improving the way innovative and needed new therapies reach patients, and...
View ArticleAn Urgent need for Partnership: UK Government’s Action on Anti-Microbial...
In a recent EFPIA newsletter, we shared an interesting and very timely announcement from UK Prime Minister David Cameron regarding Anti-Microbial Resistance. The Prime Minister made headlines with his...
View Article